lobbying_activities: 2142282

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2142282 053926d5-57d5-428f-bde6-03779fe959f4 Q2 BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC 292972 BOEHRINGER INGELHEIM USA CORPORATION 2018 second_quarter CSP Anti-Counterfeiting; S.469 - The Affordable and Safe Drug Importation Act Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   1060000 0 0 2018-07-11T12:06:37.797000-04:00